News

radiology reporting EHR health record CDS AUC

PocketHealth's latest agentic AI offering improves patient compliance, reduces administrative costs

Conductor is a platform of AI-enabled agents that can read clinical documents and orders, call patients and orchestrate appointments.

Some reviewers opposed FDA's approval of new drug for life-threatening disease

When the FDA approved elamipretide for the treatment of Barth syndrome, not everyone agreed with the agency's decision.

Eating unsalted peanuts improves the brain's vascular health

MRIs show how peanut consumption improves the brain's vascular function

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions.

Healthcare AI today: Billions for AI-based biotech, fast ROI or else, AI for imprisoned patients, more

The Zuckerbergs have many billions to give away. They want to shower a lot of it on researchers using AI to cure diseases.

Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.

CCTA will play an essential role in the cath labs of the future

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview.

Is long-term melatonin use safe? New study highlights heart risks

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep.

GLP-1 drugs and healthy lifestyle choices work in tandem to protect the heart

The rise of these medications continues to be one of the biggest stories in healthcare.

GLP-1 weight loss drugs will now be covered by Medicare and Medicaid—and available at a discount through TrumpRx

Novo Nordisk and Eli Lilly have agreed to sell their popular Wegovy and Zepbound injectables through TrumpRx.gov for a discounted rate, as the White House promises that Medicaid and Medicare plans will begin covering the costs.

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.

Gottlieb: Let’s not slap the label ‘medical device’ on AI software that only helps clinicians make care decisions

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated?

Perplexity scores improve identification of fraudulent AI writings

Though numerous web-based tools have been created to flag published works that appear suspicious for AI authorship, the performances of these tools has been inconsistent thus far.

Benzodiazepine use before heart surgery: Should it be embraced or restricted?

Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.

Around the web

Radiology Business